Supplementary Figure 11 from Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy
Year: 2026
Type: supplementary-materials
Abstract: Figure S11. Gating strategy to define % CD62L+CD45RA+ T cells (related to Figure 5A).
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165027034
